HPV and Cervical Cancer in India: 2026 Guide

What Is HPV and Why Does It Matter for Indian Women?

Human papillomavirus is the most common sexually transmitted infection in the world, and the direct cause of over 94% of all cervical cancer cases globally. Most people contract HPV at some point in their lives, yet the vast majority never develop symptoms or long-term complications.

Understanding Human Papillomavirus

HPV is a family of over 200 related viruses, transmitted through skin-to-skin contact during sexual activity ^[1]. Most strains are low-risk and resolve on their own without treatment. However, high-risk strains, particularly HPV 16 and HPV 18, can cause persistent infection that, over the years, triggers abnormal cell changes in the cervix that may progress to cancer.

Why India Carries a Disproportionate Burden

India accounts for approximately 25% of the world’s cervical cancer deaths despite having effective prevention tools available ^[2]. Low awareness, limited access to screening in rural areas, and social stigma around reproductive health discussions mean most Indian women are diagnosed at advanced stages, when treatment is significantly more complex. Addressing this gap starts with accurate information.

Is HPV Dangerous?

For most people, HPV clears naturally within one to two years without causing harm. It becomes dangerous when a high-risk strain establishes a persistent infection that the immune system fails to clear. This is the pathway through which cervical cancer develops, typically over ten to fifteen years. The long window between infection and cancer is precisely what makes screening so powerful; there is ample time to detect and treat abnormal cells before they become malignant.

Understanding HPV is the foundation, but knowing how to recognise when something may be wrong is equally critical, particularly because early-stage cervical cancer is often silent.

HPV Symptoms in Females: What to Watch For

HPV itself is largely asymptomatic. Most women with high-risk HPV strains experience no symptoms at all, which is why the infection so often goes undetected without active screening. Knowing the warning signs of cervical disease, rather than HPV infection itself, is what matters clinically.

Early Warning Signs of Cervical Abnormalities

• Unusual vaginal bleeding: Bleeding between periods, after sexual intercourse, or after menopause is the most common early symptom of cervical cancer
• Abnormal vaginal discharge: Watery, blood-tinged, or foul-smelling discharge that differs from your normal pattern
• Pelvic pain: Persistent pain in the lower abdomen or pelvis, particularly during or after intercourse, unrelated to menstruation
  Painful or frequent urination: In more advanced cases, as the tumour presses on adjacent structures

When to See a Doctor Immediately

Any unexplained post-coital bleeding, bleeding after menopause, or persistent pelvic discomfort warrants immediate gynaecological evaluation; do not wait for a scheduled check-up. These symptoms do not confirm cervical cancer, but they require clinical assessment without delay.

Early detection is the most powerful clinical tool available, but prevention through vaccination is even more effective. Here is what every Indian woman needs to know about the cervical cancer vaccine.

Cervical Cancer Vaccine in India: Everything You Need to Know

The HPV vaccine is one of modern medicine’s most effective cancer prevention tools. It works by generating an immune response against the high-risk HPV strains responsible for the majority of cervical cancers, before exposure occurs.

Here are the vaccines that are available in India:

Who Should Get Vaccinated?

• Girls aged 9-14: Two doses are sufficient at this age and provide the strongest immune response; this is the optimal vaccination window.
• Women aged 15-26: Three doses required; still highly effective, particularly if not yet sexually active.
• Women aged 27-45: Three doses; discuss with your gynaecologist, benefit depends on prior exposure history.
• Already sexually active women: Vaccination still provides meaningful protection against strains not yet encountered.

The HPV vaccine prevents infection; it does not treat existing HPV or reverse cervical changes already present. Women who have been vaccinated still require regular cervical screening, as the vaccine does not protect against all high-risk HPV strains.

Cervical Cancer Screening in India: Who Needs It and When

Cervical screening detects abnormal cell changes in the cervix before they progress to cancer. It is the single most important intervention for women who are or have been sexually active, regardless of vaccination status.

Here is a comprehensive recommended screening schedule:

Now, let’s understand the different types of cervical screening that are available in India:

• Pap smear (Pap test): Collects cells from the cervix to detect abnormalities, widely available across India’s urban hospitals and many government health centres
• HPV DNA test: Directly detects the presence of high-risk HPV strains, more sensitive than a Pap smear alone and increasingly recommended as a primary screening tool
• VIA (Visual Inspection with Acetic Acid): A low-cost, no-laboratory screening method widely used in rural India and government health programmes, an important tool where laboratory infrastructure is limited.

Is Cervical Cancer Curable? Treatment Options in 2026

Yes, cervical cancer is highly curable when detected at an early stage. Stage 1 cervical cancer carries a five-year survival rate exceeding 90%, and even Stage 2 responds well to treatment when managed by an experienced oncology team ^[3].

The critical variable is the timing of the diagnosis.

Treatment by Stage

• Pre-cancerous lesions (CIN 1, 2, 3): Abnormal cells detected through screening can be treated before they become cancerous using minimally invasive procedures, such as LEEP (Loop Electrosurgical Excision Procedure), cone biopsy, or cryotherapy. No major surgery required.
• Stage 1 (localised to cervix): Surgery, typically a radical hysterectomy, or radiation therapy, often with excellent outcomes. Fertility-sparing options are available for younger women in select cases.
• Stage 2-3 (regional spread): Concurrent chemoradiation, combining chemotherapy with radiation therapy, is the standard of care and achieves meaningful remission rates when delivered by a specialist team.
• Stage 4 (distant spread): Treatment focuses on systemic chemotherapy, targeted therapy, and immunotherapy options. Immunotherapy agents have shown improved survival outcomes in advanced cervical cancer in recent clinical trials.

If you have received an abnormal screening result, have HPV-related concerns, or are due for vaccination or a Pap smear, early specialist input makes a measurable difference in outcomes. The Oncology Department at Eskag Sanjeevani Hospital offers HPV vaccination, cervical screening, colposcopy, and comprehensive cervical cancer management, with care plans tailored to each patient’s clinical picture.